Digital Editions
Latest content
- Atrogi moves forward in phase 1 trial for oral candidate to improve metabolic and muscle health
- Sandoz appoints Armin Metzger as President of new global unit
- WHO releases new target product profiles for urgently needed antibiotics
- BioDuro appoints Andrew Thomas and Stevan Djuric as Scientific Advisors
- AstraZeneca’s Imfinzi approved in EU for early gastric and gastro-oesophageal cancers




